Habil Khorakiwala (#2956)
- $ 1 B
- pharmaceuticals
- India
- M
- 83 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Pharma tycoon Habil Khorakiwala chairs Wockhardt, one of India's top makers of generic drugs. He founded Wockhardt in 1967 after breaking away from his family's storied retailing empire. His son Murtaza runs the Mumbai company which counts the U.K. as one of its top markets.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Habil Khorakiwala’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Habil Khorakiwala’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.3B
(May 4, 2026)
© Iconic Billionaires